Search published articles


Showing 1 results for Sadati Khalili

Mahrooyeh Haji-Abolhasan Varaminfard, Mina Ebrahimi-Rad, Seifoddin Javadian, Mahmood Beheshti Monfared, Seyedeh Fatemeh Sadati Khalili, Reza Saghiri,
Volume 20, Issue 2 (6-2026)
Abstract

Background: Although several clinical and laboratory diagnostic approaches have been developed for Coronary Artery Disease (CAD), rates of mortality and morbidity have remained high, which may be due to defective diagnostic markers. Here, we evaluated the serum levels of selected trace elements (Zn, Se, and Cu) in CAD patients and healthy subjects and assessed their diagnostic values in CAD.
Methods: 53 cardiologist-approved CAD patients and 48 age and sex-matched healthy controls were recruited. The serum levels of Zn, Se, and Cu, were assessed using the atomic absorption method. GraphPad v.8.4 and SPSS v.18 software were used for statistical analyses.
Results: The serum levels of Zn and Se were significantly lower in the CAD patients than in controls (P = 0.0008 and P < 0.0001, respectively). In contrast, CAD patients showed significantly higher levels of Cu (P = 0.0064). Concerning the ROC curve analyses, the area under the curve (AUC) for Zn was 0.6563 (P = 0.0069). Setting the cut-off value at 1.255 μg/mL gave a sensitivity of 56.60%, specificity of 66.67%, and likelihood ratio (LR) of 1.698. AUC for Se was 0.8595 (P<0.0001). The optimum cut-off value at 86.50 ng/ml level gave a sensitivity of 83.02%, specificity of 75.00%, and LR of 3.321. The AUC for Cu was 0.6557 (P = 0.0071). The optimum cut-off value at 1.225 μg/mL level gave a sensitivity of 62.26%, specificity of 64.58%, and LR of 1.758.
Conclusion: Our study showed that selenium can be a biomarker with reliable diagnostic value for CAD.



Page 1 from 1